Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$47.05 USD
+0.69 (1.49%)
Updated Jul 15, 2024 04:00 PM ET
Pre-Market: $47.30 +0.25 (0.53%) 9:04 AM ET
4-Sell of 5 4
D Value F Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Exact Sciences Corporation [EXAS]
Reports for Purchase
Showing records 341 - 360 ( 367 total )
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Building a Better Screening Test - Initiating with a Buy and $10 Target
Provider: AURIGA USA
Analyst: MEHRA R
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Raising Price Target Based On Increased Confidence In The Colon Cancer Test
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
85% SENSITIVITY IN COLORECTAL CANCER; 64% SENSITIVITY IN PRE-CANCERS- BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
ANTICIPATING STRONG VALIDATION CLINICAL DATA - RAISING PRICE TARGET TO $17
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Biotechnology - Laboratory Developed Tests Panel Summary
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.